Trivant Custom Portfolio Group, LLC Moderna, Inc. Transaction History
Trivant Custom Portfolio Group, LLC
- $174 Billion
- Q1 2025
A detailed history of Trivant Custom Portfolio Group, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 20 shares of MRNA stock, worth $534. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 20
-0.0%
Holding current value
$534
Previous $832,000
31.85%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MRNA
# of Institutions
859Shares Held
251MCall Options Held
23.9MPut Options Held
30.2M-
Vanguard Group Inc Valley Forge, PA40.4MShares$1.08 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$683 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$590 Million0.48% of portfolio
-
State Street Corp Boston, MA17.8MShares$475 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.46MShares$199 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...